Developer docs
API playgroundTry for free, no card

Search company profiles

Howard Foundation

Full company profile

uuid004lkqt

Namestring
Howard Foundation
Legal namestring
The Howard Foundation
Company typeenum
Private
Founded yearint
1982
Descriptiontext

The Howard Foundation is a charitable trust established in 1982 in England and Wales, founded by Dr Alan Howard. The foundation's stated activities fall into three areas: capital support for Downing College, Cambridge; funding of carotenoid and nutrition research through clinical trials; and support for research into malnutrition and diabetes-related disease. It operates with a small staff of approximately 5 employees and a board of trustees that includes Julie Lambert (Chair), Jon Howard (Secretary), Anthony Leeds, and Alistair Lambert, following the death of the founder in 2020.

The foundation's research portfolio centers on the role of carotenoid supplementation in visual performance, cognitive function, and chronic disease prevention, funded through named clinical trials (MOST, CREST, CARDS, CARES, Re-MIND) and, as of December 2025, the CoDIAPREM malnutrition and diabetes study in Nepal. Its operating subsidiaries are Howard Foundation Research (HFR), which ran the now-closed Lipotrim weight-management programme (discontinued January 2023), and Howard Foundation Holdings. The foundation holds ISO/IEC 17025:2017 accreditation for its Supplement Certified testing program, and its carotenoid-formulation patent portfolio was transferred to Maravilla LLC in March 2023. Academic anchoring includes the Howard Chair at the Nutrition Research Centre Ireland (NRCI) at South East Technological University (SETU), held by Professor John Nolan.

As a charitable trust, the foundation is funded by an endowment rather than commercial revenue, and revenue is not publicly disclosed. Commercial monetization is indirect — primarily through licensing of patented carotenoid formulations to a small set of partners including Macuhealth, Macuprime, Re-Mind, and Memory Health — and is materially constrained following the 2023 patent transfer to Maravilla LLC. The scope of activities is bounded by charitable status and trust objectives, with no direct product sales to end consumers.

Short descriptiontext

The Howard Foundation is a UK charitable trust, established 1982, funding carotenoid and nutrition clinical research (MOST, CREST, CARDS, CARES, Re-MIND, CoDIAPREM), supporting Downing College Cambridge, and operating ISO/IEC 17025-accredited Supplement Certified testing via its subsidiary Howard Foundation Research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research funding, carotenoid clinical trials, charitable nutrition research, academic infrastructure support, eye and brain health studies
Industry2 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryNo
NAICS code3 codes
  • Voluntary Health Organizations813212
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
  • Medicinal Chemicals & Botanical Products2833
Product category
Philanthropic Biomedical Research Foundation
Social media profiles1 record
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Howard Foundation is a charitable trust established in 1982 that funds and sponsors biomedical research, with a primary focus on carotenoid research (lutein, zeaxanthin, and meso-zeaxanthin) for eye and brain health. It sponsors clinical trials, funds an endowed academic chair in human nutrition, operates a quality certification process for carotenoid supplements, and supports infrastructure and bursaries at Downing College Cambridge. Its IP is commercialized through licensed partners (Macuhealth, Macuprime, Re-Mind, Memory Health).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Re-MIND trial showed statistically significant improvements in skin carotenoid measurements, blood carotenoids, ω-3FAs, and vitamin E concentrations in active group vs placebo
+3 more records
Product overview1 text field

The Howard Foundation is a charitable trust established in 1982 that funds and sponsors biomedical research, primarily focusing on carotenoid research for eye and brain health. The Foundation's product portfolio consists of funded research programs (including clinical trials such as MOST, CREST, CARDS, CARES, and Re-MIND), an endowed academic chair at SETU, and commercialized nutritional supplements (Macuprime, Macuhealth, Re-Mind, Memory Health) developed from sponsored research. The Foundation also operates the Supplement Certified quality certification process for carotenoid supplements. Additionally, the Foundation funds physical infrastructure at Downing College Cambridge (Howard Building, Howard Lodge, Howard Theatre) and provides educational programs including the annual Howard Lecture and travel bursaries for STEM students. The Howard Laboratory at NRCI/SETU serves as the primary research facility for Foundation-sponsored work.

Product and service8 records
1Clinical Research Sponsorship
CategoryResearch funding and sponsorship
2Howard Chair in Human Nutrition
CategoryEndowed academic position
3Supplement Certified
CategoryQuality certification services
4Annual Howard Lecture
CategoryEducational lecture series
5Downing College Travel Bursary Scheme
CategoryStudent grant programme
6Howard Foundation Travel Grants (BON Conference)
CategoryResearcher grant programme
7Macuhealth and Macuprime (Licensed Trademarks)
CategoryLicensed nutritional supplement brand
8Re-Mind and Memory Health (Licensed Trademarks)
CategoryLicensed nutritional supplement brand
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Partnership with Professor Mike Lean (alumnus of Downing College) for the CoDIAPREM clinical trial in Nepal investigating community-based diabetes prevention and remission through traditional diet. The Foundation agreed to fund this four-year trial in December 2025 after UK government funding was withdrawn.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Principal sponsor of the Roger Harris Memorial Seminar held at Downing College in October 2025 on creatine and beta-alanine research.

3Supplement Certified
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-01-01
Description

Certification company created by NRCI team (led by Professor John Nolan and Dr Alfonso Prado-Cabrero) for quality control testing of carotenoid supplements. Based in the Howard Laboratory at NRCI/SETU. Gained ISO/IEC 17025:2017 accreditation from INAB in April 2024.

howard-foundation.com
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2016-01-01
Description

Commercial partner for carotenoid supplement products for eye health in North America. Co-founded Maravilla LLC with IOSA in March 2023 to take over the Howard Foundation's patent and trademark portfolio for macular carotenoids.

5Brain and Ocular Nutrition (BON) Network
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Scientific network founded by Dr Alan Howard and Professor John Nolan in 2011 (following earlier conferences on Macular Carotenoids). Organizes international conferences; Foundation provides headline sponsorship and travel grants for young researchers. BON Conference held at Downing College (2011, 2013, 2015, 2018, 2022), first USA conference in 2025.

howard-foundation.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

The Foundation has partnered with WIT/SETU since 2009 to conduct carotenoid research at the Nutrition Research Centre Ireland (NRCI). Funded a Research Fellowship for Professor John Nolan, which was converted to the Howard Chair in Human Nutrition in 2016 (running until 2031). Contributed to the Howard Laboratory (opened 2015) and Howard Gate at the NRCI campus.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2009-01-01
Description

Partnership with IOSA of Monterrey, Mexico for the supply of meso-zeaxanthin and development of micro-micelle formulations for enhanced carotenoid bioavailability. IOSA has been granted 14 US and WIPO patents for unique processes and formulations. Provided supplements used in clinical trials and formed Maravilla LLC with Macuhealth in 2023 to commercialize the patent portfolio.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1982-01-01
Description

The Foundation's primary institutional partner since 1982. Dr Howard was an alumnus (1948-2020). The Foundation has funded three major buildings: Howard Building (1987), Howard Lodge (1994), Howard Theatre (2009, £7 million). Also supports the Heong Gallery, travel bursaries for STEM students, and cultural events at the Howard Theatre.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK charity dedicated to beating macular disease through research funding and patient support. Operates in the same UK geography and macular disease research niche as the Howard Foundation.

TypeBroad incumbent
Description

Global ophthalmic company offering AREDS-based eye health supplements including PreserVision for AMD. Comparable as a broader incumbent in the macular carotenoid / eye health supplement space that competes with Howard Foundation-licensed products.

TypeDirect peer
Description

Direct commercial licensee of Howard Foundation macular carotenoid IP for North America. Operates the same carotenoid-based eye health supplement portfolio developed from Howard Foundation-sponsored research.

TypeOthers
Description

Mexican manufacturer of carotenoid ingredients and long-time Howard Foundation partner that co-developed the micro-micelle formulation and holds 14 US/WIPO patents. Ecosystem partner rather than direct competitor, providing manufacturing capability for Foundation-licensed products.

TypeBroad incumbent
Description

Global nutritional ingredients company producing carotenoids (lutein, zeaxanthin) and omega-3 oils. Comparable as a broad incumbent supplying the same macular carotenoid raw materials used in Howard Foundation-sponsored formulations.

TypeDirect peer
Description

US nonprofit that funds peer-reviewed research on macular degeneration, glaucoma, and Alzheimer's disease. Directly comparable to the Howard Foundation as a health-research grantmaking charity with overlapping disease focus areas.

TypeDirect peer
Description

US nonprofit supporting AMD research and education. Comparable as a charity focused on macular degeneration awareness and research funding with overlapping mission to Howard Foundation carotenoid research.

TypeDirect peer
Description

Nonprofit funding retinal disease research with translational pipeline from lab to clinical trials. Comparable structure as a vision-research grantmaking organization advancing macular and retinal therapeutics.

TypeDirect peer
Description

UK-based charity funding dementia research, including nutritional and lifestyle intervention studies. Comparable as a UK research-funding foundation with brain-health research overlap including Re-MIND trial focus areas.

TypeDirect peer
Description

UK charity that disseminates nutrition science and funds nutritional research. Comparable as a UK-based nutritional research charity with overlapping mission and dissemination activities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Howard Foundation

Philanthropic Biomedical Research Foundationhoward-foundation.com

The Howard Foundation is a UK charitable trust, established 1982, funding carotenoid and nutrition clinical research (MOST, CREST, CARDS, CARES, Re-MIND, CoDIAPREM), supporting Downing College Cambridge, and operating ISO/IEC 17025-accredited Supplement Certified testing via its subsidiary Howard Foundation Research.

What Howard Foundation does

The Howard Foundation is a charitable trust established in 1982 in England and Wales, founded by Dr Alan Howard. The foundation's stated activities fall into three areas: capital support for Downing College, Cambridge; funding of carotenoid and nutrition research through clinical trials; and support for research into malnutrition and diabetes-related disease. It operates with a small staff of approximately 5 employees and a board of trustees that includes Julie Lambert (Chair), Jon Howard (Secretary), Anthony Leeds, and Alistair Lambert, following the death of the founder in 2020.

The foundation's research portfolio centers on the role of carotenoid supplementation in visual performance, cognitive function, and chronic disease prevention, funded through named clinical trials (MOST, CREST, CARDS, CARES, Re-MIND) and, as of December 2025, the CoDIAPREM malnutrition and diabetes study in Nepal. Its operating subsidiaries are Howard Foundation Research (HFR), which ran the now-closed Lipotrim weight-management programme (discontinued January 2023), and Howard Foundation Holdings. The foundation holds ISO/IEC 17025:2017 accreditation for its Supplement Certified testing program, and its carotenoid-formulation patent portfolio was transferred to Maravilla LLC in March 2023. Academic anchoring includes the Howard Chair at the Nutrition Research Centre Ireland (NRCI) at South East Technological University (SETU), held by Professor John Nolan.

As a charitable trust, the foundation is funded by an endowment rather than commercial revenue, and revenue is not publicly disclosed. Commercial monetization is indirect — primarily through licensing of patented carotenoid formulations to a small set of partners including Macuhealth, Macuprime, Re-Mind, and Memory Health — and is materially constrained following the 2023 patent transfer to Maravilla LLC. The scope of activities is bounded by charitable status and trust objectives, with no direct product sales to end consumers.

Howard Foundation firmographics

Firmographics
Name
Howard Foundation
Legal name
The Howard Foundation
Website
https://howard-foundation.com
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
1–10 employees
Short description
The Howard Foundation is a UK charitable trust, established 1982, funding carotenoid and nutrition clinical research (MOST, CREST, CARDS, CARES, Re-MIND, CoDIAPREM), supporting Downing College Cambridge, and operating ISO/IEC 17025-accredited Supplement Certified testing via its subsidiary Howard Foundation Research.
Ownership category
akta.pro rank

Howard Foundation industry classification

Industry
Product category
Philanthropic Biomedical Research Foundation
NAICS
Voluntary Health Organizations (813212), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • Biomedical research funding
  • Carotenoid clinical trials
  • Charitable nutrition research
  • Academic infrastructure support
  • Eye and brain health studies

Where Howard Foundation is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Howard Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Others

Marketing channels5 records

Howard Foundation product offering

Product offering

Core offering

The Howard Foundation is a charitable trust established in 1982 that funds and sponsors biomedical research, with a primary focus on carotenoid research (lutein, zeaxanthin, and meso-zeaxanthin) for eye and brain health. It sponsors clinical trials, funds an endowed academic chair in human nutrition, operates a quality certification process for carotenoid supplements, and supports infrastructure and bursaries at Downing College Cambridge. Its IP is commercialized through licensed partners (Macuhealth, Macuprime, Re-Mind, Memory Health).

Product overview

The Howard Foundation is a charitable trust established in 1982 that funds and sponsors biomedical research, primarily focusing on carotenoid research for eye and brain health. The Foundation's product portfolio consists of funded research programs (including clinical trials such as MOST, CREST, CARDS, CARES, and Re-MIND), an endowed academic chair at SETU, and commercialized nutritional supplements (Macuprime, Macuhealth, Re-Mind, Memory Health) developed from sponsored research. The Foundation also operates the Supplement Certified quality certification process for carotenoid supplements. Additionally, the Foundation funds physical infrastructure at Downing College Cambridge (Howard Building, Howard Lodge, Howard Theatre) and provides educational programs including the annual Howard Lecture and travel bursaries for STEM students. The Howard Laboratory at NRCI/SETU serves as the primary research facility for Foundation-sponsored work.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research Sponsorship
  • Howard Chair in Human Nutrition
  • Supplement Certified
  • Annual Howard Lecture
  • Downing College Travel Bursary Scheme
  • Howard Foundation Travel Grants (BON Conference)
  • Macuhealth and Macuprime (Licensed Trademarks)
  • Re-Mind and Memory Health (Licensed Trademarks)

Quantifiable outcome

  • Re-MIND trial showed statistically significant improvements in skin carotenoid measurements, blood carotenoids, ω-3FAs, and vitamin E concentrations in active group vs placebo
  • +3 more outcomes

Companies that use Howard Foundation

Customer profile

Segments3 records

Ideal customer profiles2 records

Howard Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Howard Foundation partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • University of GlasgowcoreStrategic or Co-development Partner · 1 January 2025Partnership with Professor Mike Lean (alumnus of Downing College) for the CoDIAPREM clinical trial in Nepal investigating community-based diabetes prevention and remission through traditional diet. The Foundation agreed to fund this four-year trial in December 2025 after UK government funding was withdrawn.
  • Natural Alternatives Int Inc (NAI)minorGTM or Marketing Partner · 1 January 2025Principal sponsor of the Roger Harris Memorial Seminar held at Downing College in October 2025 on creatine and beta-alanine research.
  • Supplement CertifiedcoreTechnology or Integration · 1 January 2021Certification company created by NRCI team (led by Professor John Nolan and Dr Alfonso Prado-Cabrero) for quality control testing of carotenoid supplements. Based in the Howard Laboratory at NRCI/SETU. Gained ISO/IEC 17025:2017 accreditation from INAB in April 2024.
  • MacuhealthcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2016Commercial partner for carotenoid supplement products for eye health in North America. Co-founded Maravilla LLC with IOSA in March 2023 to take over the Howard Foundation's patent and trademark portfolio for macular carotenoids.
  • Brain and Ocular Nutrition (BON) NetworkcoreStrategic or Co-development Partner · 1 January 2011Scientific network founded by Dr Alan Howard and Professor John Nolan in 2011 (following earlier conferences on Macular Carotenoids). Organizes international conferences; Foundation provides headline sponsorship and travel grants for young researchers. BON Conference held at Downing College (2011, 2013, 2015, 2018, 2022), first USA conference in 2025.
  • Waterford Institute of Technology (WIT) / South East Technological University (SETU)coreStrategic or Co-development Partner · 1 January 2009The Foundation has partnered with WIT/SETU since 2009 to conduct carotenoid research at the Nutrition Research Centre Ireland (NRCI). Funded a Research Fellowship for Professor John Nolan, which was converted to the Howard Chair in Human Nutrition in 2016 (running until 2031). Contributed to the Howard Laboratory (opened 2015) and Howard Gate at the NRCI campus.
  • Industrial Organica (IOSA)coreStrategic or Co-development Partner · 1 January 2009Partnership with IOSA of Monterrey, Mexico for the supply of meso-zeaxanthin and development of micro-micelle formulations for enhanced carotenoid bioavailability. IOSA has been granted 14 US and WIPO patents for unique processes and formulations. Provided supplements used in clinical trials and formed Maravilla LLC with Macuhealth in 2023 to commercialize the patent portfolio.
  • Downing College, CambridgecoreStrategic or Co-development Partner · 1 January 1982The Foundation's primary institutional partner since 1982. Dr Howard was an alumnus (1948-2020). The Foundation has funded three major buildings: Howard Building (1987), Howard Lodge (1994), Howard Theatre (2009, £7 million). Also supports the Heong Gallery, travel bursaries for STEM students, and cultural events at the Howard Theatre.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Howard Foundation competitors and assessment

Company assessment

Direct peers

  • Macular Society: UK charity dedicated to beating macular disease through research funding and patient support. Operates in the same UK geography and macular disease research niche as the Howard Foundation.
  • Macuhealth: Direct commercial licensee of Howard Foundation macular carotenoid IP for North America. Operates the same carotenoid-based eye health supplement portfolio developed from Howard Foundation-sponsored research.
  • BrightFocus Foundation: US nonprofit that funds peer-reviewed research on macular degeneration, glaucoma, and Alzheimer's disease. Directly comparable to the Howard Foundation as a health-research grantmaking charity with overlapping disease focus areas.
  • American Macular Degeneration Foundation: US nonprofit supporting AMD research and education. Comparable as a charity focused on macular degeneration awareness and research funding with overlapping mission to Howard Foundation carotenoid research.
  • Foundation Fighting Blindness: Nonprofit funding retinal disease research with translational pipeline from lab to clinical trials. Comparable structure as a vision-research grantmaking organization advancing macular and retinal therapeutics.
  • Alzheimer's Research UK: UK-based charity funding dementia research, including nutritional and lifestyle intervention studies. Comparable as a UK research-funding foundation with brain-health research overlap including Re-MIND trial focus areas.
  • British Nutrition Foundation: UK charity that disseminates nutrition science and funds nutritional research. Comparable as a UK-based nutritional research charity with overlapping mission and dissemination activities.

Broad incumbents

  • Bausch + Lomb (PreserVision): Global ophthalmic company offering AREDS-based eye health supplements including PreserVision for AMD. Comparable as a broader incumbent in the macular carotenoid / eye health supplement space that competes with Howard Foundation-licensed products.
  • dsm-firmenich: Global nutritional ingredients company producing carotenoids (lutein, zeaxanthin) and omega-3 oils. Comparable as a broad incumbent supplying the same macular carotenoid raw materials used in Howard Foundation-sponsored formulations.

Others

  • Industrial Organica (IOSA): Mexican manufacturer of carotenoid ingredients and long-time Howard Foundation partner that co-developed the micro-micelle formulation and holds 14 US/WIPO patents. Ecosystem partner rather than direct competitor, providing manufacturing capability for Foundation-licensed products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Howard Foundation social profiles

Digital presence

Howard Foundation compliance and trust

Trust signal

Compliance1 record

Howard Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Howard Foundation leadership team

Management profile

Number of profiles

Profiles4 records

Howard Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Howard Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Howard Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Howard Foundation

What does Howard Foundation do?

The Howard Foundation is a charitable trust established in 1982 that funds and sponsors biomedical research, with a primary focus on carotenoid research (lutein, zeaxanthin, and meso-zeaxanthin) for eye and brain health. It sponsors clinical trials, funds an endowed academic chair in human nutrition, operates a quality certification process for carotenoid supplements, and supports infrastructure and bursaries at Downing College Cambridge. Its IP is commercialized through licensed partners (Macuhealth, Macuprime, Re-Mind, Memory Health).

Is Howard Foundation a public or private company?

Howard Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Howard Foundation founded?

Howard Foundation was founded in 1982. It employs 1 to 10 people.

Where is Howard Foundation based?

Howard Foundation is headquartered in Cambridge, United Kingdom, in the Europe region.

Who are Howard Foundation's main competitors?

Direct peers on record are Macular Society, Macuhealth, BrightFocus Foundation, American Macular Degeneration Foundation, Foundation Fighting Blindness, Alzheimer's Research UK and British Nutrition Foundation. Broad incumbents are Bausch + Lomb (PreserVision) and dsm-firmenich. Industrial Organica (IOSA) is listed as an others.

Does Howard Foundation have an API?

No public API is recorded for Howard Foundation.

What industry is Howard Foundation in?

Howard Foundation's product category is Philanthropic Biomedical Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals